We found ER-b expression in tumoral cells of prostate carcinoma in 29 of our low and intermediate grade cancers (100%) and 19 of high grade cancers (83%) but 4 high grade cancers were negative (17%). This evidence concerns the gene ESR2 and prostate carcinoma.